Insider Transactions Reported by 25 Insiders of Evelo Biosciences, Inc.

Symbol
EVLO on OTC
Location
Foxboro, MA

There are no Buy or Sell transactions made by insiders since 25 Jan 2025

Evelo Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner $4,520,548 27 May 2022
Flagship Ventures Fund IV General Partner LLC 10%+ Owner $2,617,765 11 Jul 2023
Horizon Technology Finance Corp 10%+ Owner $714,286 11 Jul 2023
David R. Epstein Director $30,998 30 Jun 2022
Mark Bodmer CSO, President of R&D $8,492 07 Nov 2023
Marella Thorell Chief Financial Officer $7,345 07 Nov 2023
SIMBA GILL President & CEO, Director $5,860 07 Nov 2023
Duncan McHale Chief Medical Officer $5,605 07 Nov 2023
Mark D. Plinio Chief Commercial Officer $1,238 31 Jan 2023
Stephen J. Carriere Principal Accounting Officer $67 19 Jan 2023
Juan Andres Director 08 Jun 2023
KYRIAZI THEO MELAS Director 08 Jun 2023
John Hohneker Director 08 Jun 2023
Jose-Carlos Gutierrez-Ramos Director 08 Jun 2023
Jonathan B. Zung Chief Development Officer 19 Jul 2022
DAVID P. PERRY Director 08 Jun 2021
Luca Scavo Cfo 19 Jan 2022
Lord Ara Darzi Director 09 Jun 2022
Robert L. Rosiello Director 08 Jun 2023
Iain B. McInnes Director 08 Jun 2023
Jeffrey R. Moore Director 11 Jul 2023
Daniel Char General Counsel 19 Jul 2022
Tonya Williams Director 08 Jun 2023
Alexander C. Reynolds Director 11 Jul 2023
Julie McHugh Director 08 Jun 2023

Recent Insider Transactions by Companies or Individuals for Evelo Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.